Regulatoriskt pressmeddelande05.03.2025 klo 14.30BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North
Regulatoriskt pressmeddelande20.02.2025 klo 21.00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy
Regulatoriskt pressmeddelande17.02.2025 klo 13.15BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt
Regulatoriskt pressmeddelande12.02.2025 klo 17.00BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Regulatoriskt pressmeddelande10.02.2025 klo 09.00BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations
Regulatoriskt pressmeddelande06.02.2025 klo 15.00BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
Regulatoriskt pressmeddelande31.01.2025 klo 16.30BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Regulatoriskt pressmeddelande18.12.2024 klo 14.00Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatoriskt pressmeddelande18.12.2024 klo 13.00BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatoriskt pressmeddelande13.12.2024 klo 13.00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
Regulatoriskt pressmeddelande13.12.2024 klo 09.30BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
Video02.12.2024 klo 16.00Life Science Companies as Investments | Life Science Night Dec. 2, 2024Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.
Regulatoriskt pressmeddelande29.11.2024 klo 16.30BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans
Regulatoriskt pressmeddelande29.11.2024 klo 16.20BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatoriskt pressmeddelande29.11.2024 klo 15.00BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company
Regulatoriskt pressmeddelande26.11.2024 klo 17.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatoriskt pressmeddelande22.11.2024 klo 19.05BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
Regulatoriskt pressmeddelande22.11.2024 klo 19.00BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations
Regulatoriskt pressmeddelande14.11.2024 klo 14.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatoriskt pressmeddelande07.11.2024 klo 13.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd